miR-22 represses cancer progression by inducing cellular senescence

Journal of Cell Biology

Volumn 193, Issue 2, 2011, Pages 409-424

  Xu, Dan ^a   Takeshita, Fumitaka ^b   Hino, Yumiko ^a   Fukunaga, Saori ^a   Kudo, Yasusei ^a   Tamaki, Aya ^a   Matsunaga, Junko ^a   Takahashi, Ryou u ^b   Takata, Takashi ^a   Shimamoto, Akira ^a   Ochiya, Takahiro ^b   Tahara, Hidetoshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 6; MICRORNA; SIRTUIN 1; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL GROWTH; CELL INVASION; CELL MOTILITY; CELL SIZE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SENESCENCE; UPREGULATION;

ANIMALS; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 6; DOWN-REGULATION; FEMALE; FIBROBLASTS; HUMANS; MICE; MICRORNAS; NEOPLASMS; SIRTUIN 1; SP1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 79955509397     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201010100     Document Type: Article

References (64)

1. Adams, P.D. 2007. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene. 397:84-93.
2. Agirre, X., A. Jiménez-Velasco, E. San José-Enériz, L. Garate, E. Bandrés, L. Cordeu, O. Aparicio, B. Saez, G. Navarro, A. Vilas-Zornoza, et al. 2008. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol. Cancer Res. 6:1830-1840.
3. Akao, Y., Y. Nakagawa, and T. Naoe. 2006. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull. 29:903-906.
4. Bar, N., and R. Dikstein. 2010. miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics. PLoS ONE. 5:e10859.
5. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297.
6. Belguise, K., N. Kersual, F. Galtier, and D. Chalbos. 2005. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene. 24:1434-1444.
7. Braig, M., S. Lee, C. Loddenkemper, C. Rudolph, A.H. Peters, B. Schlegelberger, H. Stein, B. Dörken, T. Jenuwein, and C.A. Schmitt. 2005. Oncogeneinduced senescence as an initial barrier in lymphoma development. Nature. 436:660-665.
8. Brooks, C.L., and W. Gu. 2009. How does SIRT1 affect metabolism, senescence and cancer? Nat. Rev. Cancer. 9:123-128.
9. Calin, G.A., and C.M. Croce. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 6:857-866.
10. Calin, G.A., C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C.M. Croce. 2004. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA. 101:2999-3004.
11. Campisi, J. 2005. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 120:513-522.
12. Chen, Q.M., V.C. Tu, J. Catania, M. Burton, O. Toussaint, and T. Dilley. 2000. Involvement of Rb family proteins, focal adhesion proteins and protein synthesis in senescent morphogenesis induced by hydrogen peroxide. J. Cell Sci. 113:4087-4097.
13. Chen, Y., Y. Song, Z. Wang, Z. Yue, H. Xu, C. Xing, and Z. Liu. 2010. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J. Gastrointest. Surg. 14:1170-1179.
14. Choong, M.L., H.H. Yang, and I. McNiece. 2007. MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis. Exp. Hematol. 35:551-564.
15. Collado, M., J. Gil, A. Efeyan, C. Guerra, A.J. Schuhmacher, M. Barradas, A. Benguría, A. Zaballos, J.M. Flores, M. Barbacid, et al. 2005. Tumour biology: senescence in premalignant tumours. Nature. 436:642.
16. Debacq-Chainiaux, F., J.D. Erusalimsky, J. Campisi, and O. Toussaint. 2009. Protocols to detect senescence-associated beta-galactosidase (SAbetagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4:1798-1806.
17. Deng, Y., S.S. Chan, and S. Chang. 2008. Telomere dysfunction and tumour suppression: the senescence connection. Nat. Rev. Cancer. 8:450-458.
18. Díaz, R., J. Silva, J.M. García, Y. Lorenzo, V. García, C. Peña, R. Rodríguez, C. Muñoz, F. García, F. Bonilla, and G. Domínguez. 2008. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer. 47:794-802.
19. Dimri, G.P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E.E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9367.
20. Elmén, J., M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, M. Hedtjärn, J.B. Hansen, H.F. Hansen, E.M. Straarup, et al. 2008. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36:1153-1162.
21. Fabbri, M., R. Garzon, A. Cimmino, Z. Liu, N. Zanesi, E. Callegari, S. Liu, H. Alder, S. Costinean, C. Fernandez-Cymering, et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA. 104:15805-15810.
22. Gangaraju, V.K., and H. Lin. 2009. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10:116-125.
23. Garofalo, M., and C.M. Croce. 2011. microRNAs: Master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. Toxicol. 51:25-43.
24. Haferkamp, S., S.L. Tran, T.M. Becker, L.L. Scurr, R.F. Kefford, and H. Rizos. 2009. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence. Aging (Albany NY). 1:542-556.
25. Hahn, W.C., and R.A. Weinberg. 2002. Rules for making human tumor cells. N. Engl. J. Med. 347:1593-1603.
26. He, L., and G.J. Hannon. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522-531.
27. Huang, J., Q. Gan, L. Han, J. Li, H. Zhang, Y. Sun, Z. Zhang, and T. Tong. 2008. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE. 3:e1710.
28. Hummel, R., D.J. Hussey, and J. Haier. 2010. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer. 46:298-311.
29. Ibarra, I., Y. Erlich, S.K. Muthuswamy, R. Sachidanandam, and G.J. Hannon. 2007. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev. 21:3238-3243.
30. Iliopoulos, D., K.N. Malizos, P. Oikonomou, and A. Tsezou. 2008. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS ONE. 3:e3740.
31. Jessel, R., S. Haertel, C. Socaciu, S. Tykhonova, and H.A. Diehl. 2002. Kinetics of apoptotic markers in exogeneously induced apoptosis of EL4 cells. J. Cell. Mol. Med. 6:82-92.
32. Katakowski, M., X. Zheng, F. Jiang, T. Rogers, A. Szalad, and M. Chopp. 2010. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. Cancer Invest. 28:1024-1030.
33. Kawahigashi, Y., T. Mishima, Y. Mizuguchi, Y. Arima, S. Yokomuro, T. Kanda, O. Ishibashi, H. Yoshida, T. Tajiri, and T. Takizawa. 2009. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs. J. Nippon Med. Sch. 76:188-197.
34. Kong, W., L. He, M. Coppola, J. Guo, N.N. Esposito, D. Coppola, and J.Q. Cheng. 2010. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J. Biol. Chem. 285:17869-17879.
35. Kota, J., R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, H.W. Hwang, T.C. Chang, P. Vivekanandan, M. Torbenson, K.R. Clark, et al. 2009. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005-1017.
36. Koutsodontis, G., I. Tentes, P. Papakosta, A. Moustakas, and D. Kardassis. 2001. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J. Biol. Chem. 276:29116-29125.
37. Lafferty-Whyte, K., C.J. Cairney, N.B. Jamieson, K.A. Oien, and W.N. Keith. 2009. Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. Biochim. Biophys. Acta. 1792:341-352.
38. Lee, Y.S., and A. Dutta. 2007. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21:1025-1030.
39. Li, N., H. Fu, Y. Tie, Z. Hu, W. Kong, Y. Wu, and X. Zheng. 2009. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 275:44-53.
40. Li, X., J. Liu, R. Zhou, S. Huang, S. Huang, and X.M. Chen. 2010. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Br. J. Haematol. 148:69-79.
41. Liu, L., Y. Jiang, H. Zhang, A.R. Greenlee, R. Yu, and Q. Yang. 2010. miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicol. In Vitro. 24:1168-1175.
42. Liu, Q., H. Fu, F. Sun, H. Zhang, Y. Tie, J. Zhu, R. Xing, Z. Sun, and X. Zheng. 2008. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 36:5391-5404.
43. Narita, M., and S.W. Lowe. 2005. Senescence comes of age. Nat. Med. 11:920-922.
44. Narita, M., S. Nũnez, E. Heard, M. Narita, A.W. Lin, S.A. Hearn, D.L. Spector, G.J. Hannon, and S.W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 113:703-716.
45. Neely, L.A., S. Patel, J. Garver, M. Gallo, M. Hackett, S. McLaughlin, M. Nadel, J. Harris, S. Gullans, and J. Rooke. 2006. A single-molecule method for the quantitation of microRNA gene expression. Nat. Methods. 3:41-46.
46. Ohtani, N., D.J. Mann, and E. Hara. 2009. Cellular senescence: its role in tumor suppression and aging. Cancer Sci. 100:792-797.
47. Ota, H., E. Tokunaga, K. Chang, M. Hikasa, K. Iijima, M. Eto, K. Kozaki, M. Akishita, Y. Ouchi, and M. Kaneki. 2006. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 25:176-185.
48. Pandey, D.P., and D. Picard. 2009. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol. Cell. Biol. 29:3783-3790.
49. Poliseno, L., L. Pitto, M. Simili, L. Mariani, L. Riccardi, A. Ciucci, M. Rizzo, M. Evangelista, A. Mercatanti, P.P. Pandolfi, and G. Rainaldi. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS ONE. 3:e2542.
50. Ricarte-Filho, J.C., C.S. Fuziwara, A.S. Yamashita, E. Rezende, M.J. da-Silva, and E.T. Kimura. 2009. Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer. Transl Oncol. 2:236-241.
51. Ruas, M., F. Gregory, R. Jones, R. Poolman, M. Starborg, J. Rowe, S. Brookes, and G. Peters. 2007. CDK4 and CDK6 delay senescence by kinasedependent and p16INK4a-independent mechanisms. Mol. Cell. Biol. 27:4273-4282.
52. Schmitt, C.A. 2007. Cellular senescence and cancer treatment. Biochim. Biophys. Acta. 1775:5-20.
53. Solomon, J.M., R. Pasupuleti, L. Xu, T. McDonagh, R. Curtis, P.S. DiStefano, and L.J. Huber. 2006. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol. Cell. Biol. 26:28-38.
54. Sun, F., H. Fu, Q. Liu, Y. Tie, J. Zhu, R. Xing, Z. Sun, and X. Zheng. 2008. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 582:1564-1568.
55. Tahara, H., M. Kusunoki, Y. Yamanaka, S. Matsumura, and T. Ide. 2005. G-tail telomere HPA: simple measurement of human single-stranded telomeric overhangs. Nat. Methods. 2:829-831.
56. Takakura, S., N. Mitsutake, M. Nakashima, H. Namba, V.A. Saenko, T.I. Rogounovitch, Y. Nakazawa, T. Hayashi, A. Ohtsuru, and S. Yamashita. 2008. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci. 99:1147-1154.
57. Takeshita, F., L. Patrawala, M. Osaki, R.U. Takahashi, Y. Yamamoto, N. Kosaka, M. Kawamata, K. Kelnar, A.G. Bader, D. Brown, and T. Ochiya. 2010. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol. Ther. 18:181-187.
58. Tapias, A., C.J. Ciudad, I.B. Roninson, and V. Noé. 2008. Regulation of Sp1 by cell cycle related proteins. Cell Cycle. 7:2856-2867.
59. Tazawa, H., N. Tsuchiya, M. Izumiya, and H. Nakagama. 2007. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. USA. 104:15472-15477.
60. Ting, Y., D.J. Medina, R.K. Strair, and D.G. Schaar. 2010. Differentiationassociated miR-22 represses Max expression and inhibits cell cycle progression. Biochem. Biophys. Res. Commun. 394:606-611.
61. Tryndyak, V.P., S.A. Ross, F.A. Beland, and I.P. Pogribny. 2009. Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol. Carcinog. 48:479-487.
62. Visone, R., P. Pallante, A. Vecchione, R. Cirombella, M. Ferracin, A. Ferraro, S. Volinia, S. Coluzzi, V. Leone, E. Borbone, et al. 2007. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene. 26:7590-7595.
63. Wang, G., W. Mao, S. Zheng, and J. Ye. 2009. Epidermal growth factor receptorregulated miR-125a-5p-a metastatic inhibitor of lung cancer. FEBS J. 276:5571-5578.
64. Xiong, J., Q. Du, and Z. Liang. 2010. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene. 29:4980-4988.